This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Innovations of Young-Mee Lee in Hepatitis B Research
Introduction
Young-Mee Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the purification of hepatitis B viral surface antigens. His innovative approach has the potential to enhance the efficiency of vaccine production and therapeutic applications.
Latest Patents
Young-Mee Lee holds a patent for a process titled "Process for purifying hepatitis B viral surface antigen comprising pres2 peptide." This patent describes a method that involves disrupting cells using a buffer containing a chaotropic salt to obtain a cell homogenate. The process further includes alkalifying the cell homogenate to a pH ranging from 11.0 to 13.5, which is crucial for the purification of the viral surface antigen.
Career Highlights
Currently, Young-Mee Lee is associated with LG Chemical Ltd., a leading company in the chemical and biotechnology sectors. His work at LG Chemical Ltd. focuses on advancing research and development in biopharmaceuticals, contributing to the company's reputation for innovation.
Collaborations
Young-Mee Lee collaborates with esteemed colleagues, including Soon-Jae Park and Kyung-Hee Yoon. Their combined expertise fosters a productive research environment, leading to advancements in their respective fields.
Conclusion
Young-Mee Lee's innovative work in the purification of hepatitis B viral surface antigens exemplifies the impact of biotechnology on healthcare. His contributions are paving the way for improved therapeutic solutions and vaccine development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile